Palantir Scores -80 on Weapons. They Also Score +30 on Health.
Palantir Technologies builds software that processes data at scale. The same core technology serves two very different masters.
On one side: contracts with the US Department of Defense, intelligence agencies, and military operations. On the other: partnerships with NHS hospitals and public health agencies.
The data reflects both realities.
The Full Scorecard
Average: -18. Gap between best and worst: 110 points.
The Weapons Side
The -80 on No War, No Weapons reflects Palantir's deep integration with military and intelligence operations. The company's Gotham platform was designed for counter-terrorism analysis. It holds contracts with the CIA, NSA, and US Army. In 2022, Palantir's CEO publicly stated the company's technology is used on the battlefield in Ukraine.
The Health Side
The +30 on Better Health for All is not a rounding error. Palantir's Foundry platform was deployed across the NHS during COVID-19, helping coordinate vaccine distribution and hospital capacity. The company has partnerships with public health institutions across the US and UK.
The same data integration capability that enables targeting also enables disease tracking.
The Dual-Use Problem
Palantir is the clearest example in our database of the dual-use technology paradox. The technology itself is neutral. The applications are not.
An investor who cares about weapons cannot hold Palantir. An investor who cares about health might want to. Both positions are supported by the same data.
This is why single ESG scores collapse. A company can be simultaneously among the worst and among the best -- depending on which value you measure.